Eisai Co (TSE:4523) Beta: 0.0943 (As of Jun. 25, 2026)


TSE:4523 Eisai Co Ltd TSE:4523
70 GF Score
Price 円3,890.00
GF Value 円5,701.95
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Eisai Co Beta?

Eisai Co TSE:4523 -0.10% 70 Beta is 0.0943 as of Jun. 25, 2026. GuruFocus rates TSE:4523 with a GF Score™ of 70/100 and a GF Value™ of 円5,701.95 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Eisai Co's Beta is 0.0943.


Eisai Co  (TSE:4523) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Eisai Co Beta Related Terms


Eisai Co Beta Historical Data

* Premium members only.

The historical data trend for Eisai Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eisai Co Beta Chart

Eisai Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 0.05 0.10 -0.09 0.31

Eisai Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 -0.02 0.59 0.12 0.31

TSE:4523 vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Beta distribution charts can be found below:

* The bar in red indicates where Eisai Co's Beta falls into.


TSE:4523
70GF Score
Eisai Co Ltd TSE:4523
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eisai Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.0943 mean?
Eisai Co (TSE:4523) has a Beta of 0.0943 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Eisai Co and its competitors.
Is Eisai Co's Beta too high?
Eisai Co's current Beta is 0.0943. Overall, Eisai Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eisai Co's Beta compare to ZTS?
Eisai Co's Beta of 0.0943 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Eisai Co and its competitors. Eisai Co's current Beta is 0.0943. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eisai Co stock overvalued right now?
Based on GuruFocus' analysis, Eisai Co (TSE:4523) is currently considered Significantly Undervalued. The stock's GF Value™ is 円5,701.95, compared to a current price of 円3,890.00 — trading 31.8% below its estimated fair value. The current Beta is 0.0943. Eisai Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Eisai Co (TSE:4523), the current Beta is 0.0943 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eisai Co (TSE:4523) Overvalued in 2026?

Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued. The current stock price of 円3,890.00 is trading 31.8% below its estimated GF Value™ of 円5,701.95. GuruFocus considers Eisai Co to be Significantly Undervalued.

Key valuation signals for TSE:4523:

  • Beta: 0.0943
  • GF Value™: 円5,701.95 vs. price of 円3,890.00 (31.8% below fair value)
  • GF Score™: 70/100 with 7 warning signs

No single metric tells the full story. See the TSE:4523 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eisai Co Business Description

Address 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
70GF Score

Get the complete analysis for TSE:4523

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,890.00
Price
円5,701.95
GF Value